Background. The extracellular matrix proteoglycans decorin and biglycan may
have a pathogenic role in renal fibrosing disease via regulation of the ac
tivity of growth factors, such as transforming growth factor-beta, and effe
cts on collagen type I fibrillogenesis. The expression of decorin and bigly
can in human glomerular diseases characterized by mesangial sclerosis is un
known.
Methods. Decorin, biglycan, and collagen type I were localized immunohistoc
hemically in human renal biopsy cases of amyloidosis (N = 18), diabetic nep
hropathy (N = 11), fibrillary glomerulonephritis (N = 5), immunotactoid glo
merulopathy (N = 5), light-chain deposition disease (N = 4), idiopathic mes
angial sclerosis (N = 4), and nephrosclerosis (N = 6), and in morphological
ly normal tissues obtained from tumor nephrectomies (N = 8). Decorin and bi
glycan mRNA synthesis was evaluated by in situ hybridization.
Results. Decorin and biglycan protein were not identified in normal glomeru
li. Decorin accumulated in amyloid deposits, but not in deposits of fibrill
ary glomerulonephritis or immunotactoid glomerulopathy. Biglycan weakly acc
umulated in amyloid deposits, and both decorin and biglycan weakly stained
mesangial nodules in cases of morphologically advanced light-chain depositi
on disease and diabetic nephropathy. In all analyzed cases, irrespective of
the underlying disease, decorin and biglycan accumulated in glomeruli in a
reas of fibrous organization of the urinary space and in areas of tubuloint
erstitial fibrosis. Biglycan, but not decorin, accumulated in the neointima
of arteriosclerotic blood vessels. Decorin and biglycan mRNA synthesis was
detected at sites of proteoglycan accumulation in glomeruli, interstitium,
and neointima. Collagen type I colocalized with decorin and biglycan depos
its.
Conclusions, Differences in extracellular matrix proteoglycan composition m
ay be diagnostically useful in distinguishing morphologically similar disea
ses. Distinct patterns of proteoglycan expression may be related to modulat
ion of specific growth factor activity in different glomerular diseases.